Consequently, ATN-224-treated cancer cells enter programmed caspase-mediated apoptosis in vitro and in vivo (110, 158) suggesting SOD1 as a tumor promoter and a potential novel target for cancer therapy. This evidence concerns the gene SOD1 and neoplasm.